ClinicalTrials.Veeva

Menu
A

Ambulatorium Sp. z o.o. | Ambulatorium Sp. z o.o. - Elblag, Poland

Research site
(Unclaimed)

Site insights

Top conditions

Top treatments

JNJ-77242113
Retatrutide
LY3437943
Eloralintide
Zasocitinib
Icotrokinra
TAK-279
Orforglipron
Tirzepatide
LY3841136

Curious how this site stacks up to its peers?

Data sourced from clinicaltrials.gov

Work at this site?

CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.

Learn more and claim site

Active trials

9 of 11 total trials

A Study of Eloralintide (LY3841136) in Participants With Obesity or Overweight, and Type 2 Diabetes (ENLIGHTEN-2)

The main purpose of this study is to evaluate the efficacy and safety of eloralintide compared with placebo for body weight reduction in participants...

Enrolling
Overweight
Obesity
Drug: Eloralintide
Drug: Placebo

The purpose of this study is to evaluate the efficacy of guselkumab treatment in participants with active psoriatic arthritis (PsA) axial disease by...

Active, not recruiting
Arthritis, Psoriatic
Drug: Placebo
Drug: Guselkumab

The purpose of this study is to measure cardiovascular outcomes with orforglipron compared with placebo in participants with atherosclerotic cardiova...

Enrolling
Chronic Kidney Disease
Atherosclerosis Cardiovascular Disease
Drug: Orforglipron
Drug: Placebo

The main purpose of this study is to evaluate the efficacy and safety of retatrutide once weekly in participants with obesity and established cardiov...

Active, not recruiting
Obesity
Cardiovascular Diseases
Drug: Retatrutide
Drug: Placebo
Locations recently updated

The main aim of this study is to check the side effects of TAK-279 and how well it is tolerated in participants with moderate-to-severe plaque psoria...

Active, not recruiting
Plaque Psoriasis
Drug: TAK-279

This study will investigate the effect of tirzepatide on the reduction of morbidity and mortality in adults living with obesity and provide additiona...

Active, not recruiting
Overweight
Obesity
Drug: Placebo
Drug: Tirzepatide
Locations recently updated

Psoriatic arthritis (PsA) is a chronic inflammatory disease that affects the joints and skin in people who have psoriasis (PsO).The main aim of the s...

Enrolling
Psoriatic Arthritis
Drug: Active Comparator
Drug: Zasocitinib

The purpose of this study is to evaluate the efficacy of icotrokinra (JNJ-77242113) compared to placebo in biologic-experienced and biologic-naive pa...

Enrolling
Arthritis, Psoriatic
Drug: Placebo
Drug: Icotrokinra

The purpose of this study is to evaluate the efficacy of icotrokinra compared to placebo in participants with active psoriatic arthritis (PsA) by ass...

Active, not recruiting
Arthritis, Psoriatic
Drug: Placebo
Drug: Active reference comparator

Trial sponsors

Lilly logo
Janssen (J&J Innovative Medicine) logo
Takeda logo

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems